MedPath

Prediction of Volume Responsiveness in Presence of Left Ventricular Diastolic Dysfunction

Not Applicable
Conditions
Hemodynamics
Interventions
Other: intubation and mechanical ventilation
Other: central venous catheter
Other: premedication
Other: transpulmonary thermodilution catheter
Other: passive leg raising
Other: arterial catheter
Other: transesophageal echocardiography
Registration Number
NCT02441621
Lead Sponsor
University Hospital Schleswig-Holstein
Brief Summary

The ability of the global end-diastolic volume index (GEDVI), stroke volume variation (SVV) and pulse pressure variation (PPV) for prediction of fluid responsiveness in presence of left ventricular diastolic dysfunction is still unknown. The aim of the present study was to challenge the predictive power of GEDVI, SVV and PPV in cardiac surgery patients undergoing aortic valve replacement.

Detailed Description

All patients receive premedication with midazolam 7.5 mg p.o.. After induction of anesthesia with sufentanil (0.5 µg/kg) and propofol (1.5 mg/kg), orotracheal intubation is facilitated with rocuronium (0.6 mg/kg). Anesthesia is maintained with sufentanil (1 µg/kg/h) and propofol (3 mg/kg/h) and patients are ventilated with an oxygen/air mixture in volume-controlled mode, using a tidal volume of 8 ml/kg related to the ideal body weight. Positive end-expiratory pressure is set at 5 cmH2O. Continuous monitoring is performed including electrocardiogram, radial arterial pressure catheter and a central venous catheter in the right or left internal jugular vein. Before placement of a transpulmonary thermodilution catheter a transesophageal echocardiography (TOE) is performed. TOE is used to detect diastolic dysfunction of the left ventricle and to exclude right ventricular dysfunction. In presence of left ventricular dysfunction a transpulmonary thermodilution catheter is placed in the femoral artery and connected to a PiCCO2 monitor (PiCCO2, Pulsion Medical Systems, Munich, Germany). Additionally capnography, urine output, temperature (blood, bladder and nasopharyngeal), airway pressure, and pulse oximetry are recorded.

Before starting operation a passive leg raising is performed. The passive leg raising maneuver (PLR) involves a leg elevation up to 45° with the trunk in a horizontal position and was performed to induce hemodynamic effects by a volume challenge, turning unstressed blood volume to stressed volume proportional to body size. In case of an increase of stroke volume index (SVI) \>15% during PLR, patients were defined as responders.

All patients were studied with no changes in anesthesia management. Measurements of SVI, GEDVI, SVV and PPV are performed before, during and after PLR. Thereafter, patients receive a fluid Bolus of 500 ml crystalloids. Again, measurements are performed before and after fluid replacement.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients > 18 yrs of age
  • Patients with a left ventricular ejection fraction ≥0.5
  • Patients with left ventricular diastolic dysfunction.
Exclusion Criteria
  • Emergency procedures
  • Right ventricular dysfunction
  • Hemodynamic instability requiring pharmacologic Support
  • Ongoing arrhythmia
  • Intracardiac Shunts
  • Severe mitral stenosis or insufficiency
  • Aortic aneurysm > 4 cm
  • Use of an artificial left ventricular assist device or intra - aortic balloon pump.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
intubation and mechanical ventilationintubation and mechanical ventilation-
central venous cathetercentral venous catheter-
premedicationpremedication-
transpulmonary thermodilution cathetertranspulmonary thermodilution catheter-
Passive leg raisingpassive leg raising-
arterial catheterarterial catheterContinuous monitoring is performed including electrocardiogram, radial arterial pressure catheter
transesophageal echocardiographytransesophageal echocardiography-
Primary Outcome Measures
NameTimeMethod
Increase in stroke volume index (SVI) >15%Patients will be obtained until the end of the operation, an expected average of 5 hours

In presence of an increase of SVI \>15% during PLR and/or 500 ml crystalloids, patients are defined as responders.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ole Broch

🇩🇪

Kiel, Schleswig-Holstein, Germany

© Copyright 2025. All Rights Reserved by MedPath